IMPORTANT REMINDER: New DEA Education Requirement on Opioid or other Substance Use Disorders Begins June 27

June 8, 2023

Beginning June 27, DEA license holders, upon initial registration or renewal, will be required to complete at least eight hours of training in the treatment or management of patients with opioid or other substance use disorders. 

To ensure you have the most accurate information, you should review the guidance issued by the DEA. Click here to find the MMA’s recommendations for members who need to complete this training. 

Latest News

State Launches New Resource to Guide Patients to Non-Opioid Treatments

June 4, 2026

The Minnesota Department of Health (MDH), in partnership with Hennepin Healthcare, is launching a new online resource called NOPAIN MN that is geared toward helping Minnesotans manage their pain without opioids. 

MMA Seeks Volunteers for Task Force on Medical Liability

June 4, 2026

The MMA Advocacy & Policy Committee (APC) is seeking physician volunteers to serve on its newly created Medical Liability Task Force.  

Key MMA Priorities Signed into Law by Gov. Walz

May 28, 2026

This week, Gov. Tim Walz signed into law several key healthcare provisions supported by the MMA.